March 04, 2015 3:34 PM ET

Pharmaceuticals

Company Overview of Merck Serono S.A.

Company Overview

Merck Serono S.A., a biopharmaceutical company, discovers, develops, manufactures, and commercializes prescription medicines of chemical and biological origin in specialist indications. It develops drugs for neurodegenerative diseases, such as Rebif, a disease modifying drug to treat relapsing forms of multiple sclerosis; and Erbitux, an IgG1 monoclonal antibody targeting the epidermal growth factor receptor for treating squamous cell carcinoma of the head and neck, and metastatic colorectal cancer. The company also develops fertility drugs for various stages of the reproductive cycle and recombinant versions of various hormones needed to treat infertility, such as GONAL-f, a recombinant hum...

Frankfurter Strasse 250

Darmstadt,  64293

Germany

Founded in 1987

4,775 Employees

Phone:

49 6151 72 0

Fax:

49 6151 72 2000

Key Executives for Merck Serono S.A.

Chief Executive Officer and President
Age: 54
Head of Global Business Unit Allergy and Chief Executive Officer of Allergopharma
Age: 43
Chief Executive Officer of Consumer Health and President of Consumer Health
Head of Legal and Senior Vice President
Age: 76
Head of Global Business Development and Executive Vice President of Global Business Development & Strategy
Compensation as of Fiscal Year 2014.

Merck Serono S.A. Key Developments

Merck Serono Reports Revenue Results for the Year 2014

Merck Serono reported revenue results for the year 2014. For the year, the company's revenue declined by 1.4% year on year to EUR 5.975 billion, although its sales were up by 1.7% year on year.

Merck Serono Pharmaceuticals Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 08:55 AM

Merck Serono Pharmaceuticals Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 08:55 AM. Venue: The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St, 40th Floor (D Elevator Bank), New York, NY10007, United States. Speakers: Catherine Pickering, Head of Oncology Licensing, Global BD.

Merck Serono S.A. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 08:00 AM

Merck Serono S.A. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 08:00 AM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States. Speakers: Catherine-Anne Pickering, Head, Oncology Licensing and Global Business Development.

Similar Private Companies By Industry

Company Name Region
MCM Klosterfrau Vertriebsgesellschaft mbH Europe
Aurigon Life Science GmbH Europe
Sanofi-Aventis Deutschland GmbH Europe
Jomaa Pharmaka GmbH Europe
Biofrontera Pharma GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Merck Serono S.A., please visit www.merckserono.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.